Brian Wodlinger
Research Subjects
Brian Wodlinger has a total of 95 co-authors. Here are the top co-authors by number of shared publications:
- Dominique M. Durand
Department of Biomedical Engineering, Case Western Reserve University, Cleveland, OH, USA
14 shared publications - Jennifer L. Collinger
Rehab Neural Engineering Labs, University of Pittsburgh
6 shared publications - Elizabeth C. Tyler-Kabara
University of Pittsburgh
5 shared publications - Michael L. Boninger
Rehab Neural Engineering Labs, University of Pittsburgh, Pittsburgh, PA, USA
4 shared publications - Sangeet Ghai
University Medical Imaging Toronto, Joint Department of Medical Imaging, University Health Network–Mount Sinai Hospital–Women’s College Hospital, University of Toronto, Toronto General Hospital, Toronto, Canada
4 shared publications Wei Wang
University of Pittsburgh
4 shared publications
Latest Publications
- Open Access
Data-Efficient Prostate Micro-Ultrasound Image Analysis using a Modality-specific Foundation Model ⋆
Background and Objective: Micro-ultrasound (MicroUS) is an emerging high-resolution imaging modality for prostate cancer diagnosis and real-time biopsy guidance, but its automated analysis is limited by labor-intensive expert annotation. We aimed to develop and evaluate a foundation model for data-efficient MicroUS image analysis. Methods: We developed µ FM, a MicroUS-specific foundation model pretrained using DINOv2-style self-supervised learning on 1,736,391 unlabeled images from 780 patients. The model was fine-tuned and evaluated in three downstream cohorts for prostate capsule segmentation (public, 75 patients), urethra segmentation (institutional, 105 patients), and prostate cancer lesion localization (institutional, 190 patients). Under limited annotation, µ FM was compared with randomly initialized models and foundation models pretrained on natural, medical, and ultrasound images. Evaluation used the Dice scores and 95th-percentile Hausdorff distance (HD95) for segmentation and free-response receiver operating characteristic analysis for lesion localization. Key Findings and Limitations: µ FM improved performance across all three tasks, with the largest gains under limited annotation. With 10% of training scans, µ FM achieved Dice scores of 93.8% for prostate capsule segmentation and 58.4% for urethra segmentation, versus 87.9% and 47.0% for the strongest comparators. Corresponding HD95 values were 2.0 and 4.3 mm. For lesion localization, µ FM outperformed other models with approximately 0.75 sensitivity at two false-positive detections per 3D volume. Limitations include retrospective single-institution pretraining and lack of explicit 3D modeling. Conclusions and Clinical Implications: MicroUS-specific self-supervised pretraining improved data-efficient image analysis across prostate and urethra segmentation, and lesion localization. This approach may reduce annotation requirements for developing automated tools in MicroUS image analysis. Advancing Practice: What does the study add?: This study evaluates a deep learning model pretrained on a large-scale dataset of unlabeled prostate MicroUS images. The pretrained model was adapted to three clinically relevant image-analysis tasks: prostate capsule segmentation, urethra segmentation, and prostate cancer lesion localization. Substantial performance gains over other models were observed despite limited training data, suggesting that MicroUS-specific self-supervised pretraining may reduce expert annotation requirements for developing automated image-analysis tools. Patient Summary: We developed a foundation model that learns from unlabeled prostate MicroUS images. It performed better with limited labeled data but requires independent validation before clinical use.
Open AccessData-Efficient Prostate Micro-Ultrasound Image Analysis using a Modality-specific Foundation Model ⋆
Background and Objective: Micro-ultrasound (MicroUS) is an emerging high-resolution imaging modality for prostate cancer diagnosis and real-time biopsy guidance, but its automated analysis is limited by labor-intensive expert annotation. We aimed to develop and evaluate a foundation model for data-efficient MicroUS image analysis. Methods: We developed µ FM, a MicroUS-specific foundation model pretrained using DINOv2-style self-supervised learning on 1,736,391 unlabeled images from 780 patients. The model was fine-tuned and evaluated in three downstream cohorts for prostate capsule segmentation (public, 75 patients), urethra segmentation (institutional, 105 patients), and prostate cancer lesion localization (institutional, 190 patients). Under limited annotation, µ FM was compared with randomly initialized models and foundation models pretrained on natural, medical, and ultrasound images. Evaluation used the Dice scores and 95th-percentile Hausdorff distance (HD95) for segmentation and free-response receiver operating characteristic analysis for lesion localization. Key Findings and Limitations: µ FM improved performance across all three tasks, with the largest gains under limited annotation. With 10% of training scans, µ FM achieved Dice scores of 93.8% for prostate capsule segmentation and 58.4% for urethra segmentation, versus 87.9% and 47.0% for the strongest comparators. Corresponding HD95 values were 2.0 and 4.3 mm. For lesion localization, µ FM outperformed other models with approximately 0.75 sensitivity at two false-positive detections per 3D volume. Limitations include retrospective single-institution pretraining and lack of explicit 3D modeling. Conclusions and Clinical Implications: MicroUS-specific self-supervised pretraining improved data-efficient image analysis across prostate and urethra segmentation, and lesion localization. This approach may reduce annotation requirements for developing automated tools in MicroUS image analysis. Advancing Practice: What does the study add?: This study evaluates a deep learning model pretrained on a large-scale dataset of unlabeled prostate MicroUS images. The pretrained model was adapted to three clinically relevant image-analysis tasks: prostate capsule segmentation, urethra segmentation, and prostate cancer lesion localization. Substantial performance gains over other models were observed despite limited training data, suggesting that MicroUS-specific self-supervised pretraining may reduce expert annotation requirements for developing automated image-analysis tools. Patient Summary: We developed a foundation model that learns from unlabeled prostate MicroUS images. It performed better with limited labeled data but requires independent validation before clinical use.
- Open Access
- 26 September 2025
- Published by Elsevier in Ultrasonics
- Vol. 158, 107811
Three-dimensional quantitative elastography using micro-ultrasound: Proof of concept
- 26 September 2025
- Published by Elsevier in Ultrasonics
- Vol. 158, 107811
Open AccessThree-dimensional quantitative elastography using micro-ultrasound: Proof of concept
- 15 April 2020
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Transactions on Medical Imaging
- Vol. 39 (10) , 3148-3158
Improving Prostate Cancer (PCa) Classification Performance by Using Three-Player Minimax Game to Reduce Data Source Heterogeneity
PCa is a disease with a wide range of tissue patterns and this adds to its classification difficulty. Moreover, the data source heterogeneity, i.e. inconsistent data collected using different machines, under different conditions, by different operators, from patients of different ethnic groups, etc., further hinders the effectiveness of training a generalized PCa classifier. In this paper, for the first time, a Generative Adversarial Network (GAN)-based three-player minimax game framework is used to tackle data source heterogeneity and to improve PCa classification performance, where a proposed modified U-Net is used as the encoder. Our dataset consists of novel high-frequency ExactVu ultrasound (US) data collected from 693 patients at five data centers. Gleason Scores (GSs) are assigned to the 12 prostatic regions of each patient. Two classification tasks: benign vs. malignant and low-vs. high-grade, are conducted and the classification results of different prostatic regions are compared. For benign vs. malignant classification, the three-player minimax game framework achieves an Area Under the Receiver Operating Characteristic (AUC) of 93.4%, a sensitivity of 95.1% and a specificity of 87.7%, respectively, representing significant improvements of 5.0%, 3.9%, and 6.0% compared to those of using heterogeneous data, which confirms its effectiveness in terms of PCa classification.
- 15 April 2020
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Transactions on Medical Imaging
- Vol. 39 (10) , 3148-3158
Improving Prostate Cancer (PCa) Classification Performance by Using Three-Player Minimax Game to Reduce Data Source Heterogeneity
PCa is a disease with a wide range of tissue patterns and this adds to its classification difficulty. Moreover, the data source heterogeneity, i.e. inconsistent data collected using different machines, under different conditions, by different operators, from patients of different ethnic groups, etc., further hinders the effectiveness of training a generalized PCa classifier. In this paper, for the first time, a Generative Adversarial Network (GAN)-based three-player minimax game framework is used to tackle data source heterogeneity and to improve PCa classification performance, where a proposed modified U-Net is used as the encoder. Our dataset consists of novel high-frequency ExactVu ultrasound (US) data collected from 693 patients at five data centers. Gleason Scores (GSs) are assigned to the 12 prostatic regions of each patient. Two classification tasks: benign vs. malignant and low-vs. high-grade, are conducted and the classification results of different prostatic regions are compared. For benign vs. malignant classification, the three-player minimax game framework achieves an Area Under the Receiver Operating Characteristic (AUC) of 93.4%, a sensitivity of 95.1% and a specificity of 87.7%, respectively, representing significant improvements of 5.0%, 3.9%, and 6.0% compared to those of using heterogeneous data, which confirms its effectiveness in terms of PCa classification.
- 30 August 2018
- Published by Canadian Urological Association Journal in Canadian Urological Association Journal
- Vol. 13 (3) , E70-E77
Comparison of conventional transrectal ultrasound, magnetic resonance imaging, and micro-ultrasound for visualizing prostate cancer in an active surveillance population: A feasibility study
Introduction: Active surveillance monitoring of prostate cancer is unique in that most patients have low-grade disease that is not well-visualized by any common imaging technique. High-resolution (29 MHz) micro-ultrasound is a new, real-time modality that has been demonstrated to be sensitive to significant prostate cancer and effective for biopsy targeting. This study compares micro-ultrasound imaging with magnetic resonance imaging (MRI) and conventional ultrasound for visualizing prostate cancer in active surveillance. Methods: Nine patients on active surveillance were imaged with multiparametric (mp) MRI prior to biopsy. During the biopsy procedure, imaging and target identification was first performed using conventional ultrasound, then using micro-ultrasound. The mpMRI report was then unblinded and used to determine cognitive fusion targets. Using micro-ultrasound, biopsy samples were taken from targets in each modality, plus 12 systematic samples. Results: mpMRI and micro-ultrasound both demonstrated superior sensitivity to Gleason sum 7 or higher cancer compared to conventional ultrasound (p=0.02 McNemar’s test). Micro-ultrasound detected 89% of clinically significant cancer, compared to 56% for mpMRI. Conclusions: Micro-ultrasound may provide similar sensitivity to clinically significant prostate cancer as mpMRI and visualize all significant mpMRI targets. Unlike mpMRI, micro-ultrasound is performed in the office, in real-time during the biopsy procedure, and so is expected to maintain the cost-effectiveness of conventional ultrasound. Larger studies are needed before these results may be applied in a clinical setting.
- 30 August 2018
- Published by Canadian Urological Association Journal in Canadian Urological Association Journal
- Vol. 13 (3) , E70-E77
Comparison of conventional transrectal ultrasound, magnetic resonance imaging, and micro-ultrasound for visualizing prostate cancer in an active surveillance population: A feasibility study
Introduction: Active surveillance monitoring of prostate cancer is unique in that most patients have low-grade disease that is not well-visualized by any common imaging technique. High-resolution (29 MHz) micro-ultrasound is a new, real-time modality that has been demonstrated to be sensitive to significant prostate cancer and effective for biopsy targeting. This study compares micro-ultrasound imaging with magnetic resonance imaging (MRI) and conventional ultrasound for visualizing prostate cancer in active surveillance. Methods: Nine patients on active surveillance were imaged with multiparametric (mp) MRI prior to biopsy. During the biopsy procedure, imaging and target identification was first performed using conventional ultrasound, then using micro-ultrasound. The mpMRI report was then unblinded and used to determine cognitive fusion targets. Using micro-ultrasound, biopsy samples were taken from targets in each modality, plus 12 systematic samples. Results: mpMRI and micro-ultrasound both demonstrated superior sensitivity to Gleason sum 7 or higher cancer compared to conventional ultrasound (p=0.02 McNemar’s test). Micro-ultrasound detected 89% of clinically significant cancer, compared to 56% for mpMRI. Conclusions: Micro-ultrasound may provide similar sensitivity to clinically significant prostate cancer as mpMRI and visualize all significant mpMRI targets. Unlike mpMRI, micro-ultrasound is performed in the office, in real-time during the biopsy procedure, and so is expected to maintain the cost-effectiveness of conventional ultrasound. Larger studies are needed before these results may be applied in a clinical setting.
- 1 July 2018
- Published by Elsevier in Ultrasound in Medicine & Biology
- Vol. 44 (7) , 1341-1354
High-Frequency Quantitative Ultrasound for Imaging Prostate Cancer Using a Novel Micro-Ultrasound Scanner
- 1 July 2018
- Published by Elsevier in Ultrasound in Medicine & Biology
- Vol. 44 (7) , 1341-1354
High-Frequency Quantitative Ultrasound for Imaging Prostate Cancer Using a Novel Micro-Ultrasound Scanner
- 1 December 2016
- Published by Elsevier in European Urology Supplements
- Vol. 15 (12) , e1499-e1500
Using patient screening data and machine learning algorithms to improve PRI-MUS™ accuracy with micro-ultrasound-based prostate biopsies
- 1 December 2016
- Published by Elsevier in European Urology Supplements
- Vol. 15 (12) , e1499-e1500
Using patient screening data and machine learning algorithms to improve PRI-MUS™ accuracy with micro-ultrasound-based prostate biopsies
- 1 December 2016
- Published by Elsevier in European Urology Supplements
- Vol. 15 (12) , e1516-e1517
Promising initial results of semi-automated quantitative-ultrasound-based algorithm for assessment of prostate cancer using a novel 29 MHz micro-ultrasound
- 1 December 2016
- Published by Elsevier in European Urology Supplements
- Vol. 15 (12) , e1516-e1517
Promising initial results of semi-automated quantitative-ultrasound-based algorithm for assessment of prostate cancer using a novel 29 MHz micro-ultrasound
- 1 December 2016
- Published by Elsevier in European Urology Supplements
- Vol. 15 (12) , e1513-e1514
Micro-ultrasound of the prostate, PRI-MUS™ protocol guidance along with clinical variables: Combined approach for reducing unnecessary biopsies
- 1 December 2016
- Published by Elsevier in European Urology Supplements
- Vol. 15 (12) , e1513-e1514
Micro-ultrasound of the prostate, PRI-MUS™ protocol guidance along with clinical variables: Combined approach for reducing unnecessary biopsies
- 1 August 2016
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 196 (2) , 562-569
Assessing Cancer Risk on Novel 29 MHz Micro-Ultrasound Images of the Prostate: Creation of the Micro-Ultrasound Protocol for Prostate Risk Identification
Conventional ultrasound systems operate at 6 to 9 MHz and serve as the standard of care to guide prostate biopsies. We present a protocol using a novel high resolution (29 MHz) transrectal prostate micro-ultrasound system. This protocol includes a scoring system to assess the risk of prostatic carcinoma and enable real-time targeted biopsies. The ExactVu™ system is currently being used in a multisite, 2,000-patient, randomized clinical trial. Cine loops of 400 biopsies from this trial were used to create the PRI-MUS™ (prostate risk identification using micro-ultrasound) protocol and risk scale. Validation was performed in an independent, pathology blinded set of 100 cines. Three of the 5 investigators performing this validation were familiar with micro-ultrasound but naïve to the PRI-MUS protocol and they received only 1 hour of training. Each increase in risk score demonstrated a 10.1% increase (95% CI 9.3-10.8) in the probability of clinically significant cancer. The risk score also increased with Gleason sum and cancer length with a slope of 0.15 (95% CI 0.09-0.21) and 0.58 (95% CI 0.43-0.73), respectively. Sensitivity and specificity were 80% and 37%, respectively, and the mean ± SD ROC AUC was 60% ± 2%. The protocol was more accurate for detecting high grade disease (Gleason sum greater than 7) with a peak AUC of 74% (mean 66%). The new resolution of the micro-ultrasound platform paired with the PRI-MUS protocol shows promise for real-time visualization of suspicious lesions and targeting of biopsies. The improved performance of the protocol in more significant disease is consistent with the focus of the field on decreasing insignificant diagnoses and detecting high risk disease early.
- 1 August 2016
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 196 (2) , 562-569
Assessing Cancer Risk on Novel 29 MHz Micro-Ultrasound Images of the Prostate: Creation of the Micro-Ultrasound Protocol for Prostate Risk Identification
Conventional ultrasound systems operate at 6 to 9 MHz and serve as the standard of care to guide prostate biopsies. We present a protocol using a novel high resolution (29 MHz) transrectal prostate micro-ultrasound system. This protocol includes a scoring system to assess the risk of prostatic carcinoma and enable real-time targeted biopsies. The ExactVu™ system is currently being used in a multisite, 2,000-patient, randomized clinical trial. Cine loops of 400 biopsies from this trial were used to create the PRI-MUS™ (prostate risk identification using micro-ultrasound) protocol and risk scale. Validation was performed in an independent, pathology blinded set of 100 cines. Three of the 5 investigators performing this validation were familiar with micro-ultrasound but naïve to the PRI-MUS protocol and they received only 1 hour of training. Each increase in risk score demonstrated a 10.1% increase (95% CI 9.3-10.8) in the probability of clinically significant cancer. The risk score also increased with Gleason sum and cancer length with a slope of 0.15 (95% CI 0.09-0.21) and 0.58 (95% CI 0.43-0.73), respectively. Sensitivity and specificity were 80% and 37%, respectively, and the mean ± SD ROC AUC was 60% ± 2%. The protocol was more accurate for detecting high grade disease (Gleason sum greater than 7) with a peak AUC of 74% (mean 66%). The new resolution of the micro-ultrasound platform paired with the PRI-MUS protocol shows promise for real-time visualization of suspicious lesions and targeting of biopsies. The improved performance of the protocol in more significant disease is consistent with the focus of the field on decreasing insignificant diagnoses and detecting high risk disease early.
- 24 March 2015
- Published by Springer Nature
- p. 78-80
Peripheral Nerve Interfaces: Overview